| Literature DB >> 30366917 |
Pernille Pedersen1, Merete Labriola2, Claus Vinther Nielsen2, Rikke Damkjær Maimburg3,4, Ellen Aagaard Nohr5, Anne-Mette Momsen1.
Abstract
OBJECTIVES: The high rate of sickness absence from work during pregnancy is recognised as a problem, and may be higher than necessary from a health perspective. The aim was to evaluate the effectiveness of interventions in healthcare settings and workplaces targeting sickness absence among pregnant women.Entities:
Keywords: absenteeism; intervention; occupational exposure; pregnancy; sick leave
Mesh:
Year: 2018 PMID: 30366917 PMCID: PMC6224771 DOI: 10.1136/bmjopen-2018-024032
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses Flow diagram. Moher et al. 49
Quality assessment of studies
| Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | Q12 | Q13 | |
| Included studies | |||||||||||||
| Quality assessment of RCTs | |||||||||||||
| Elden | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y | Y | Y |
| Elden | Y | Y | Y | N | N | Y | Y | Y | Y | Y | Y | Y | Y |
| Kihlstrand | Y | Y | Y | N | N | NA | Y | Y | Y | Y | Y | Y | Y |
| Mørkved | Y | Y | Y | N | N | Y | Y | Y | Y | Y | Y | Y | Y |
| Stafne | Y | Y | Y | N | N | NA | Y | Y | Y | Y | Y | Y | Y |
| Excluded studies | |||||||||||||
| Quality assessment of RCTs | |||||||||||||
| Ostrgaard | Y | N | Y | N | N | NA | N | N | N | Y | Y | N | Y |
| Granath | Y | N | Y | N | N | U | Y | N | Y | Y | Y | Y | Y |
| Quality assessment of quasi-experimental studies | |||||||||||||
| Norèn | N | U | U | Y | N | Y | U | U | N | – | – | – | – |
| Sydsjö | Y | Y | U | Y | N | Y | Y | Y | N | – | – | – | – |
Quality assessment of RCTs:
Q1. Was true randomisation used for assignment of participants to treatment groups?
Q2. Was allocation to treatment groups concealed?
Q3. Were treatment groups similar at the baseline?
Q4. Were participants blind to treatment assignment?
Q5. Were those delivering treatment blind to treatment assignment?
Q6. Were outcomes assessors blind to treatment assignment?
Q7. Were treatment groups treated identically other than the intervention of interest?
Q8. Was follow-up complete, and if not, were strategies to address incomplete follow-up used?
Q9. Were participants analysed in the groups to which they were randomised?
Q10. Were outcomes measured in the same way for treatment groups?
Q11. Were outcomes measured in a reliable way?
Q12. Was appropriate statistical analysis used?
Q13. Was the trial design appropriate, and any deviations from the standard RCT design (individual randomisation, parallel groups) accounted for in the conduct and analysis of the trial?
Quality assessment of quasi-experimental studies:
Q1. Is it clear in the study what is the ‘cause’ and what is the ‘effect’ (ie, there is no confusion about which variable comes first)?
Q2. Were the participants included in any comparisons similar?
Q3. Were the participants included in any comparisons receiving similar treatment/care, other than the exposure or intervention of interest?
Q4. Was there a control group?
Q5. Were there multiple measurements of the outcome both pre and post the intervention/exposure?
Q6. Was follow-up complete and if not, were differences between groups in terms of their follow-up adequately described and analysed?
Q7. Were the outcomes of participants included in any comparisons measured in the same way?
Q8. Were outcomes measured in a reliable way?
Q9. Was appropriate statistical analysis used?
N, no; NA, not applicable; RCT, randomised controlled trial; U, unclear; Y, yes.
Characteristics and results from the included studies
| Author/year/country | Population/ | Intervention group (IG) | Comparison group (CG) | Outcome | Results on sickness absence |
| Elden | Healthy women, acupuncture-naive with singleton fetuses, at 12–29 completed gestational weeks. Experiencing evening pain and diagnosed with PGP. n=115 | Acupuncture+standard therapy. | Acupuncture performed as non-penetrating sham+standard therapy. | Sickness absence frequency. | Frequency of women on sickness absence at follow-up—IG 14/58 (24%)—CG 32/57 |
| Elden | Healthy women with singleton fetuses, at 12–29 completed gestational weeks. | Craniosacral therapy+standard therapy. | Standard therapy: information from physiotherapist about PGP and anatomy. | Sickness absence frequency. | Frequency of women on sickness absence at follow-up—IG 15/63 (24%)—CG 10/60 (17%) p=0.28 |
| Kihlstrand | Women ≥18 years with an expected normal pregnancy and in 15–18 weeks of gestation. | Water gymnastics, based on a recommended programme: 17–20 times, once a week. | No intervention. | Sickness absence during pregnancy due to back pain. | Frequency of women on sickness absence at any time during follow-up—IG: 16/124 (13%)—CG: 26/120 (22%), p=0.09. |
| Mørkved | Healthy nulliparous women. | Aerobic training and pelvic floor muscle exercises. Led by physiotherapist. | Customary information given by their midwife or GP. | Sickness absence due to pelvic girdle or low back pain: ‘Have you been/are you now on sick leave because of pain in the pelvic girdle or lower back?’ | Women on sickness absence at any time during pregnancy—IG:31/148 (21%)—CG:38/153 (25%), p=0.42. |
| Stafne | Women ≥18 years, with a singleton live fetus and 18–22 weeks of gestation. | Exercise programme (aerobic activity, strength training and balance exercise) for 60 min in groups once a week for 12 weeks. | Standard antenatal care and information from midwife or GP. n=426 | Prevalence of sickness absence due to LPP. | Women on sickness absence at follow-up—IG: 89/397 (22%)—CG:111/365 (30%). |
GP, general practitioner; LPP, lumbopelvic pain; PFM, pelvic floor muscle; PGP, pelvic girdle pain.